Institutional members access full text with Ovid®

Share this article on:

Resolution of Conjunctival Sessile Hemangioma With Topical Timolol

Lubahn, Jordon G. MD; Lee, Richard K. MD, PhD; Karp, Carol L. MD

doi: 10.1097/ICO.0000000000000022
Case Report

Purpose: To report a single case of acquired sessile hemangioma of the conjunctiva which resolved after treatment with topical timolol.

Methods: Case report and literature review.

Results: A 77-year-old African American woman developed an acquired sessile hemangioma of the conjunctiva of the right eye. She was followed for primary open-angle glaucoma, and the lesion was monitored for 12 months without change. Topical timolol-dorzolamide was then added to her glaucoma medication regimen twice daily. On follow-up examination 6 months later, the lesion had completely resolved.

Conclusions: In this case report, an acquired sessile hemangioma of the conjunctiva resolved with topical timolol therapy.

Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL.

Reprints: Carol L. Karp, Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, 900 NW 17th St, Miami, FL 33136 (e-mail: ckarp@med.miami.edu).

Supported in part by NIH Center Core Grant P30EY014801, Research to Prevent Blindness Medical Student Fellowship, Department of Defense (DOD; Grant W81XWH-09-1-0675), The Ronald and Alicia Lepke Grant, The Jimmy and Gay Bryan Grant, The Lee and Claire Hager Grant.

The authors have no other funding or conflicts of interest to disclose.

Received July 27, 2013

Accepted October 01, 2013

Copyright © 2014 Wolters Kluwer Health, Inc. All rights reserved.